Whipple's Disease: Panniculitis Among Other Dermatoses. A Case Report and Literature Review

Read full text
Authors: Alfonso Agüera‐Sánchez, María del Carmen Brufau‐Redondo, Enrique Poblet
Cited by: 1
References: 23

Abstract

Whipple's disease (WD) is a rare infectious disease caused by Tropheryma whipplei , which primarily affects the gastrointestinal tract but may also involve the joints, central nervous system, and skin. Although cutaneous manifestations are often overlooked, they can provide valuable diagnostic clues. We report the case of a 54-year-old male with long-standing seronegative migratory polyarthritis refractory to conventional treatment, who subsequently developed multiple subcutaneous inflammatory nodules and systemic symptoms. Histopathological examination of these lesions revealed a non-vasculitic, septal-predominant panniculitis with foamy macrophages containing periodic acid-Schiff (PAS)-positive diastase-resistant intracytoplasmic inclusions, raising a strong suspicion of Whipple's disease. Subsequent duodenal biopsies confirmed the diagnosis by electron microscopy and polymerase chain reaction (PCR) for T. whipplei . Panniculitis in WD represents a highly specific but rarely reported finding, characterized by thickened subcutaneous septa with partial lobular involvement, foamy macrophage infiltration, and absence of vasculitis. A literature review identified 15 cases of histologically confirmed WD-associated panniculitis, suggesting that this manifestation may be under-recognized in clinical practice. This study underscores the importance of cutaneous pathology in WD and expands current knowledge on its dermatological manifestations by providing clinicopathologic, ultrastructural, and literature-based data.

Fields of Study & Subjects

Whipple's Disease and Interleukins Hypertrophic osteoarthropathy and related conditions Gastroesophageal reflux and treatments

Publication details

Journal / source
Journal of Cutaneous Pathology
Publisher
Wiley
Volume
53
Issue
6
Pages
468–474
Publication date
3 February 2026
Language
EN